Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

The maximum days for obtaining a report for the Cyclin-D1 Test Immunohistochemistry is typically 7-10 days. However, this may vary depending on the specific laboratory or healthcare facility conducting the test.

What are the prerequisites for the test Cyclin-D1 Test Immunohistochemistry

  • Tissue sample fixed in neutral buffered formalin
  • Properly labeled slides with patient information
  • Antibodies for Cyclin-D1
  • Immunohistochemistry staining reagents
  • Microscope for examination

What are the measure values for the test Cyclin-D1 Test Immunohistochemistry

  • Positive: Strong nuclear staining in more than 50% of tumor cells
  • Weak positive: Weak nuclear staining in less than 50% of tumor cells
  • Negative: No nuclear staining or weak staining in less than 10% of tumor cells

What does this test Cyclin-D1 Test Immunohistochemistry identify?

This test identifies the presence of Cyclin-D1 protein in tissue samples. Cyclin-D1 is a regulatory protein involved in cell cycle progression, specifically in the G1 phase. Overexpression of Cyclin-D1 has been linked to various cancers, particularly in breast cancer and mantle cell lymphoma. Immunohistochemistry is used to detect the protein in tissue samples by using specific antibodies that bind to Cyclin-D1.

Why is this test Cyclin-D1 Test Immunohistochemistry taken?

Cyclin-D1 Test Immunohistochemistry

Why is the Cyclin-D1 Test Immunohistochemistry taken?

The Cyclin-D1 Test Immunohistochemistry is taken to detect the presence of Cyclin-D1 protein in cells. Cyclin-D1 is a protein that plays a key role in cell cycle regulation, specifically in the G1 phase. Abnormal levels of Cyclin-D1 can be indicative of various types of cancers, including breast cancer, mantle cell lymphoma, and squamous cell carcinoma.

By performing this test, healthcare providers can determine if there is overexpression of Cyclin-D1, which can help in the diagnosis and treatment of these cancers. The test is commonly used in conjunction with other diagnostic tools, such as imaging studies and biopsies, to provide a comprehensive assessment of a patient's condition.

No FAQs available.

Customer Google Rating